필로카르핀 점안액이 기초눈물분비량에 미치는 영향

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effect of topical pilocarpine on basic tear secretion, using the Schirmer test. Methods: The Schirmer test was performed in 22 eyes of 11 healthy volunteers before instillation and at 10, 20, and 30 minutes after instillation of 1% pilocarpine and in 22 eyes of 12 healthy volunteers before instillation and at 10, 20, and 30 minutes after instillation of 2% pilocarpine. As for control group, the Schirmer test was performed in 22 eyes of 11 healthy volunteers by the same method except with normal saline. Results: The ratio of tear secretion was calculated by dividing the wet length of a Schirmer strip after instillation by the wet length before instillation for comparative analysis. In the control group, the mean ratio decreased with time to 0.78 at 10 minutes, 0.64 at 20 minutes, and 0.63 at 30 minutes after instillation of normal saline. In the 1% pilocarpine group, the mean ratio decreased with time, but there was no significant difference in comparison to the ratio of the control group. In the 2% pilocarpine group, the ratio increased significantly to 1.28 (p<0.001) at 10 minutes, 1.07 (p=0.002) at 20 minutes, and decreased to 0.63 (p=0.041) at 30 minutes after instillation. Conclusions: The basic tear secretion did not change significantly after instillation of 1% pilocarpine but increased significantly at 10 minutes after instillation of 2% pilocarpine to the highest level observed, which was followed by a decrease in basic tear secretion.

참고문헌 (Reference)

1 "dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients" A multicenter 1124-31, jclinoncol1993

2 "Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction" 71 : 1848-51, 1993

3 "The treatment of Sjogren's syndrome patients with pilocarpine tablets" 30 : 1-13, 2001

4 "Tear absorption into the filter-paper strip used in the Schirmer I test:a methodological study and a critical survey" 60 : 70-8, 1982

5 "Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels" 31 : 1381-8, 1990

6 "Secretion and execretion in normal eyes of Korean" 28 : 1-8, 1987

7 "Schirmer test:a closer look" 101 : 1383-6, 1983

8 "Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren's syndrome: a randomized placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group" 159 : 174-181, 1999

9 "Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome:a randomized 12 week controlled study" 62 : 1204-1207, 2003

10 "Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer" 329 : 390-5, 1993

11 "Lacrimation in normal eyes" 49 : 185-, 1953

12 "Effect of topical pilocarpine treatment on tear production in dogs" 205 : 1286-9, 1994

13 "Distribution pattern of nervous tissue and peptidergic nerve fibers in accessory lacrimal glands" 16 : 298-302, 1997

14 "Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca" 106 : 570-4, 1988

15 "Decreased basal tear production associated with general anesthesia" 40 : 683-687, 1999

16 "A study of the conjunctival epithelial changes in patients with dry eye syndrome by impression cytology and comparisons of those results with BUT,Schirmer test,rose bengal staining" 35 : 362-70, 1994

17 "A double-blind randomized,placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca" 56 : 748-754, 2002